Literature DB >> 31700878

Comprehensive circular RNA profiling identifies CircFAM120A as a new biomarker of hypoxic lung adenocarcinoma.

Xinghua Cheng1, Jin Qiu2, Sainan Wang2, Yunhai Yang1, Mingwei Guo2, Dongmei Wang2, Qingquan Luo1, Lingyan Xu2.   

Abstract

BACKGROUND: Hypoxia is crucial in the initiation and progression of tumor metastasis. Circular RNAs (CircRNAs) comprise a novel group of non-coding, RNase R resistant and regulatory RNAs which are generated by 'back-splicing' processes. However, the characterization and function of circRNAs in hypoxic cancer cells remain unknown.
METHODS: High throughput RNA-seq assay was performed in lung adenocarcinoma cells (A549) under either normoxic or hypoxic conditions. Bioinformatic analysis of differentially expressed circRNAs was conducted and their target genes were predicted and partially confirmed.
RESULTS: Hypoxia increased the expression of hypoxia-inducible factor 1 alpha (HIF-1α) and its downstream genes in A549 cells and enhanced cell migration ability. Comprehensive analysis of global circRNAs expression profiles of A549 identified a total of 558 circRNAs candidates, among which 65 circRNAs were differentially expressed (35 upregulated and 30 downregulated) in hypoxic cancer cells. The difference in their circRNA expressions were compared by computational analysis and circRNA-miRNA networks were constructed. We further characterized one circRNA (hsa_circ_0008193) derived from the FAM120A gene and renamed it as circFAM120A. The expression of circFAM120A, as validated by reverse transcription polymerase chain reaction, was significantly downregulated in both hypoxic A549 and lung cancer tissue from patients with lymph node metastasis. Gene ontology (GO) enrichment analysis and KEGG pathway analysis revealed that circFAM120A may participate in lung cancer development.
CONCLUSIONS: CircRNAs profiles were altered in lung adenocarcinoma under hypoxia and circFAM120A may have the potential to be a new biomarker of lung adenocarcinoma hypoxia. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Lung cancer; circular RNA; hypoxia; tumor metastasis

Year:  2019        PMID: 31700878      PMCID: PMC6803186          DOI: 10.21037/atm.2019.08.79

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  37 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis.

Authors:  Yan Li; Qiupeng Zheng; Chunyang Bao; Shuyi Li; Weijie Guo; Jiang Zhao; Di Chen; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Cell Res       Date:  2015-07-03       Impact factor: 25.617

Review 3.  Minimally Invasive Thoracic Surgery 3.0: Lessons Learned From the History of Lung Cancer Surgery.

Authors:  Xinghua Cheng; Mark W Onaitis; Thomas A D'amico; Haiquan Chen
Journal:  Ann Surg       Date:  2018-01       Impact factor: 12.969

4.  circRNA biogenesis competes with pre-mRNA splicing.

Authors:  Reut Ashwal-Fluss; Markus Meyer; Nagarjuna Reddy Pamudurti; Andranik Ivanov; Osnat Bartok; Mor Hanan; Naveh Evantal; Sebastian Memczak; Nikolaus Rajewsky; Sebastian Kadener
Journal:  Mol Cell       Date:  2014-09-18       Impact factor: 17.970

5.  Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer.

Authors:  Shuangyan Tan; Qiheng Gou; Wenchen Pu; Chenglin Guo; Yun Yang; Ke Wu; Yaxin Liu; Lunxu Liu; Yu-Quan Wei; Yong Peng
Journal:  Cell Res       Date:  2018-04-08       Impact factor: 25.617

6.  Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.

Authors:  Roderick J Phillips; Javier Mestas; Mehrnaz Gharaee-Kermani; Marie D Burdick; Antonio Sica; John A Belperio; Michael P Keane; Robert M Strieter
Journal:  J Biol Chem       Date:  2005-03-31       Impact factor: 5.157

7.  Identification and Characterization of Hypoxia-Regulated Endothelial Circular RNA.

Authors:  Jes-Niels Boeckel; Nicolas Jaé; Andreas W Heumüller; Wei Chen; Reinier A Boon; Konstantinos Stellos; Andreas M Zeiher; David John; Shizuka Uchida; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-09-16       Impact factor: 17.367

8.  Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung; Wen-Juei Jeng; Teh-Ying Chou; Wen-Hu Hsu; Kou-Juey Wu; Biing-Shiun Huang; Yu-Chung Wu
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

9.  Precise Diagnosis of Intraoperative Frozen Section Is an Effective Method to Guide Resection Strategy for Peripheral Small-Sized Lung Adenocarcinoma.

Authors:  Shilei Liu; Rui Wang; Yang Zhang; Yuan Li; Chao Cheng; Yunjian Pan; Jiaqing Xiang; Yawei Zhang; Haiquan Chen; Yihua Sun
Journal:  J Clin Oncol       Date:  2015-11-23       Impact factor: 44.544

Review 10.  Hypoxic control of metastasis.

Authors:  Erinn B Rankin; Amato J Giaccia
Journal:  Science       Date:  2016-04-07       Impact factor: 47.728

View more
  14 in total

Review 1.  Hypoxia-Induced circRNAs in Human Diseases: From Mechanisms to Potential Applications.

Authors:  Qi Huang; Juan Yang; Robby Miguel Wen-Jing Goh; Mingliang You; Lingzhi Wang; Zhaowu Ma
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

2.  Circular RNA _0015278 inhibits the progression of non-small cell lung cancer through regulating the microRNA 1278/SOCS6 gene axis.

Authors:  Yiwang Ye; Xuan Wu; Feihu Long; Wei Yue; Da Wu; Yuancai Xie
Journal:  Ann Transl Med       Date:  2021-08

3.  CircHIPK3 Promotes Gemcitabine (GEM) Resistance in Pancreatic Cancer Cells by Sponging miR-330-5p and Targets RASSF1.

Authors:  Yunfei Liu; Li Xia; Luo Dong; Jiale Wang; Qiangsheng Xiao; Xiao Yu; Hongwei Zhu
Journal:  Cancer Manag Res       Date:  2020-02-11       Impact factor: 3.989

Review 4.  The interplay between HIF-1α and noncoding RNAs in cancer.

Authors:  Xiafeng Peng; Han Gao; Rui Xu; Huiyu Wang; Jie Mei; Chaoying Liu
Journal:  J Exp Clin Cancer Res       Date:  2020-02-03

Review 5.  Hypoxia-Induced Non-Coding RNAs Controlling Cell Viability in Cancer.

Authors:  Maria Magdalena Barreca; Chiara Zichittella; Riccardo Alessandro; Alice Conigliaro
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

6.  Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.

Authors:  Suo Liu; Zhibin Jiang; Peng Xiao; Xiaozhi Li; Yinji Chen; Hao Tang; Yanfei Chai; Yicai Liu; Zhao Zhu; Qianyi Xie; Wei He; Yuchao Ma; Longyu Jin; Wei Feng
Journal:  Cancer Sci       Date:  2021-11-15       Impact factor: 6.716

Review 7.  Circular RNAs regulate cancer-related signaling pathways and serve as potential diagnostic biomarkers for human cancers.

Authors:  Pranavi Garlapati; Jinjie Ling; Paul J Chiao; Jie Fu
Journal:  Cancer Cell Int       Date:  2021-06-23       Impact factor: 5.722

8.  A Regulatory Axis of circ_0008193/miR-1180-3p/TRIM62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells Under Hypoxia.

Authors:  Minbiao Chen; Xiuming Huang; Liang Li; Mingfang Huang; Renzhong Cai; Xuqiang Liao
Journal:  Med Sci Monit       Date:  2020-08-12

9.  Circular RNA hsa_circ_0003141 promotes tumorigenesis of hepatocellular carcinoma via a miR-1827/UBAP2 axis.

Authors:  Yong Wang; Rongfen Gao; Jinpeng Li; Shaotao Tang; Shuai Li; Qiangsong Tong; Yongzhong Mao
Journal:  Aging (Albany NY)       Date:  2020-05-28       Impact factor: 5.682

10.  Hypoxia induces tumor cell growth and angiogenesis in non-small cell lung carcinoma via the Akt-PDK1-HIF1α-YKL-40 pathway.

Authors:  Yushan Miao; Wei Wang; Yaping Dong; Jiaxun Hu; Kunchen Wei; Shuo Yang; Xueli Lai; Hao Tang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.